Boston Children’s uses AI to unlock new diagnoses

Boston Children’s deployed OpenAI to diagnose 40+ rare diseases, signaling a shift toward clinical AI adoption. For the 2026 AI economy, this validates enterprise-grade models in high-stakes healthcare. Expect accelerated investment in HIPAA-compliant diagnostic tools and operational AI, reducing burdens while expanding revenue opportunities—critical as AI’s healthcare market targets $188B by 2026.